Sana Biotechnology Statistics
Total Valuation
SANA has a market cap or net worth of $361.16 million. The enterprise value is $334.19 million.
Important Dates
The last earnings date was Monday, March 17, 2025, after market close.
| Earnings Date | Mar 17, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
SANA has 225.02 million shares outstanding. The number of shares has increased by 18.69% in one year.
| Current Share Class | 225.02M |
| Shares Outstanding | 225.02M |
| Shares Change (YoY) | +18.69% |
| Shares Change (QoQ) | +0.38% |
| Owned by Insiders (%) | 8.90% |
| Owned by Institutions (%) | 60.24% |
| Float | 134.14M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.53 |
| P/TBV Ratio | 7.59 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.54, with a Debt / Equity ratio of 0.41.
| Current Ratio | 3.54 |
| Quick Ratio | 3.36 |
| Debt / Equity | 0.41 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -99.17% and return on invested capital (ROIC) is -45.61%.
| Return on Equity (ROE) | -99.17% |
| Return on Assets (ROA) | -31.82% |
| Return on Invested Capital (ROIC) | -45.61% |
| Return on Capital Employed (ROCE) | -59.59% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.38M |
| Employee Count | 194 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -82.90% in the last 52 weeks. The beta is 1.64, so SANA's price volatility has been higher than the market average.
| Beta (5Y) | 1.64 |
| 52-Week Price Change | -82.90% |
| 50-Day Moving Average | 2.81 |
| 200-Day Moving Average | 3.85 |
| Relative Strength Index (RSI) | 32.07 |
| Average Volume (20 Days) | 3,554,589 |
Short Selling Information
The latest short interest is 39.89 million, so 17.73% of the outstanding shares have been sold short.
| Short Interest | 39.89M |
| Short Previous Month | 42.00M |
| Short % of Shares Out | 17.73% |
| Short % of Float | 29.74% |
| Short Ratio (days to cover) | 14.72 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -271.47M |
| Pretax Income | -244.90M |
| Net Income | -266.76M |
| EBITDA | -255.97M |
| EBIT | -271.47M |
| Earnings Per Share (EPS) | -$1.16 |
Full Income StatementBalance Sheet
The company has $152.50 million in cash and $101.90 million in debt, giving a net cash position of $50.60 million or $0.22 per share.
| Cash & Cash Equivalents | 152.50M |
| Total Debt | 101.90M |
| Net Cash | 50.60M |
| Net Cash Per Share | $0.22 |
| Equity (Book Value) | 250.50M |
| Book Value Per Share | 1.12 |
| Working Capital | 115.38M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$223.15 million and capital expenditures -$33.43 million, giving a free cash flow of -$256.58 million.
| Operating Cash Flow | -223.15M |
| Capital Expenditures | -33.43M |
| Free Cash Flow | -256.58M |
| FCF Per Share | -$1.14 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |